- AI
- Molecular Imaging
- CT
- X-Ray
- Ultrasound
- MRI
- Facility Management
- Mammography
Amersham launches new package
Two x-ray contrast media sold by Amersham Health are now available in unbreakable bottles that are smaller and lighter than their glass equivalents. Omnipaque and isosmolar Visipaque are being packaged in the polymer bottles, which the company describes
Two x-ray contrast media sold by Amersham Health are now available in unbreakable bottles that are smaller and lighter than their glass equivalents. Omnipaque and isosmolar Visipaque are being packaged in the polymer bottles, which the company describes as being less vulnerable to accidents and easier to store. The new bottle and its contents have a three-year shelf-life. Both agents are also available in traditional glass bottles.
MRI-Based AI Radiomics Model Offers 'Robust' Prediction of Perineural Invasion in Prostate Cancer
July 26th 2024A model that combines MRI-based deep learning radiomics and clinical factors demonstrated an 84.8 percent ROC AUC and a 92.6 percent precision-recall AUC for predicting perineural invasion in prostate cancer cases.
Breast MRI Study Examines Common Factors with False Negatives and False Positives
July 24th 2024The absence of ipsilateral breast hypervascularity is three times more likely to be associated with false-negative findings on breast MRI and non-mass enhancement lesions have a 4.5-fold likelihood of being linked to false-positive results, according to new research.
Can Polyenergetic Reconstruction Help Resolve Streak Artifacts in Photon Counting CT?
July 22nd 2024New research looking at photon-counting computed tomography (PCCT) demonstrated significantly reduced variation and tracheal air density attenuation with polyenergetic reconstruction in contrast to monoenergetic reconstruction on chest CT.
